Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | marketing@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36?Washington?Street, Wellesley?Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
AZD8542 | C25H24N4O2 | 1126366-36-6 | Details |
S107 hydrochloride | C11H16ClNOS | 1357476-46-0 | Details |
UPGL00004 | C25H26N8O2S2 | 1890169-95-5 | Details |
Bryostatin 3 | C46H64O17 | 143370-84-7 | Details |
RS 100329 hydrochloride | C20H26ClF3N4O3 | 1215654-26-4 | Details |
S 14506 hydrochloride | C24H27ClFN3O2 | 286369-38-8 | Details |
NAS181;NAS-181 | C20H30N2O7S | 1217474-40-2 | Details |
(S)-(+)-Niguldipine hydrochloride | C36H40ClN3O6 | 113145-69-0 | Details |
RS-25344 hydrochloride | C19H14ClN5O4 | 152815-28-6 | Details |
alphaSYN-IN-NAB2;alphaSYNINNAB2;alphaSYN IN NAB2;alphaSYN inhibitor NAB2;NAB2;alphaSYN inhibitor-NAB2 | C23H20ClN3O | 1504588-00-4 | Details |
Dodine;Cyprex;Melprex 65;ENT 16,436;Karpen;Syllit 65 | C15H33N3O2 | 2439-10-3 | Details |
Eugenone;Eugenon;J167.369F | C13H16O5 | 480-27-3 | Details |
Conjugated Estrogen sodium;Conest;Conjugated estrogens;HSDB 3076;Estrogens, conjugated;Kestrin;TAG-39 | C18H19NaO5S | 12126-59-9 | Details |
PU3;PU 3;PU-3 | C19H25N5O3 | 352519-21-2 | Details |
AKI603 | C19H23N9O2 | 1432515-73-5 | Details |
BCI-137;BCI137;BCI 137 | C11H11N3O6S | 112170-24-8 | Details |
BRD2492 | C20H18N4O2 | 1821669-43-5 | Details |
DJ101;DJ-101;DJ 101 | C23H20N4O3 | 1803242-21-8 | Details |
EG1 | C22H18N2O5 | 693241-54-2 | Details |
HTH-01-091;HTH01-091;HTH-01091;HTH01091;HTH 01091;HTH 01-091 | C26H28Cl2N4O2 | 2000209-42-5 | Details |
MAC173979;MAC 173979;MAC-173979 | C9H5Cl2NO3 | 41501-64-8 | Details |
VU0661013 | C39H39Cl2N5O4 | 2131184-57-9 | Details |
Fosmetpantotenate;RE024;RE 024;RE-024 | C20H31N2O9P | 1858268-66-2 | Details |
Atiprimod dimaleate;SK&F 106615;SK&F106615;SK&F-106615 | C26H48N2O4 | 183063-72-1 | Details |
ER819762 | C30H39N3O3 | 1155773-15-1 | Details |
TC-Mps1-12 | C17H20N6O | 1206170-62-8 | Details |
RMM-46;RMM 46;RMM46 | C24H26N4O5 | 1307896-46-3 | Details |
Perfluoro(1,3-dimethylcyclohexane);Cyclohexane, decafluoro-1,3-bis(trifluoromethyl)-;Cyclohexane, perfluoro-1,3-dimethyl-;Hexadecafluoro-1,3-dimethylcyclohexane | C8F16 | 335-27-3 | Details |
LDN-209929 2HCl;LDN-209929 dihydrochloride;LDN209929 2HCl;LDN209929 dihydrochloride;LDN 209929 2HCl;LDN 209929 dihydrochloride | C17H17ClN2OS | 1233355-57-1 | Details |
GSK317354A;GSK 317354A;GSK-317354A | C25H18F4N6O | 874119-13-8 | Details |
FR-193879;FR193879;FR 193879 | C20H18N4O5S3 | 194928-82-0 | Details |
JNJ-17156516;JNJ 17156516;JNJ17156516 | C26H22Cl2N2O3 | 649551-06-4 | Details |
NS-2359 free base;NS-2359;GSK372475;NS 2359;GSK 372475;NS2359;GSK-372475 | C16H21Cl2NO | 195875-68-4 | Details |
Xestospongin C | C28H50N2O2 | 88903-69-9 | Details |
JNJ-26146900;JNJ26146900;JNJ 26146900 | C15H15F3N2O3S | 868691-50-3 | Details |
JNJ-19567470;JNJ 19567470;JNJ19567470 | C22H27BrN4O | 724471-26-5 | Details |
Ropsacitinib | C20H17N9 | 2127109-84-4 | Details |
Methotrexate monohydrate;Methotrexate hydrate | C20H22N8O5 | 6745-93-3 | Details |
Dexamethasone phosphate;Hexadrol phosphate;EGP437;Neodecadron;EGP 437;EGP-437 | C22H30FO8P | 312-93-6 | Details |
Anecortave;AL 4940;AL-4940;AL4940 | C21H28O4 | 10184-70-0 | Details |
Fascaplysin chloride;NSC-622398;Fascaplysin;NSC 622398;NSC622398 | C18H11ClN2O | 114719-57-2 | Details |
MSX-3;MSX 3;MSX3 | C21H21N4O7P.2Na | 261717-23-1 | Details |
NIDA 41020 | C23H24Cl2N4O2 | 502486-89-7 | Details |
Ro 41-0960 | C13H8FNO5 | 125628-97-9 | Details |
LY 165163;LY-165,163;LY165,163;LY 165,163 | C19H22F3N3 | 1814-64-8 | Details |
2-TEDC | C16H13NO4S | 132465-10-2 | Details |
Diazaborine;SA-84474;Diazaborine compound 2b18;Pkf 84.474;Pkf 84474;Pkf-84474 | C14H13BN2O3S | 22959-81-5 | Details |
Tanomastat | C23H19ClO3S | 179545-77-8 | Details |
Salvinorin A | C23H28O8 | 83729-01-5 | Details |
Ampreloxetine;TD-9855;TD 9855;TD9855 | C18H18F3NO | 1227056-84-9 | Details |
Satavaptan fumarate;SR121463A;SR-121463 A;SR-121463A;SR 121463 A | C37H49N3O12S | 185913-79-5 | Details |
Alaproclate, (S)-;(-)-Alaproclate;S-(-)-Alaproclate | C13H18ClNO2 | 66171-75-3 | Details |
PR5-LL-CM01 | C23H27N7 | 1005307-86-7 | Details |
Pentachloropseudilin;PClP | C10H4Cl5NO | 69640-38-6 | Details |
SMP-797 HCl;SMP-797;SMP 797;SMP797 | C34H44ClN5O4 | 259224-95-8 | Details |
Sabizabulin | C21H19N3O4 | 1332881-26-1 | Details |
MARK4 inhibitor 1 | C20H18N6O3 | 2271081-58-2 | Details |
VU0467485;AZ13713945 | C17H17FN4O2S | 1451994-10-7 | Details |
SHP836 | C16H19Cl2N5 | 1957276-35-5 | Details |
Nifeviroc | C33H42N4O6 | 934740-33-7 | Details |
PKR-IN-C51;PKR inhibitor C51;PKRINC51;PKR-inhibitor-C51;PKR IN C51 | C23H21N5 | 1314594-23-4 | Details |
XX-650-23 | C18H12N2O2 | 117739-40-9 | Details |
nNOS-IN-25;nNOS IN 25;nNOSIN25;nNOS inhibitor 25;nNOS inhibitor-25 | C21H22N4 | 1895092-16-6 | Details |
BETi-211 | C26H29N7O3 | 1995867-02-1 | Details |
HIV-1 Inhibitor 18A | C14H11N5O2S | 331261-50-8 | Details |
A-315675;A315675;A 315675 | C17H30N2O4 | 335679-69-1 | Details |
Relmapirazin | C12H16N6O8 | 1313706-17-0 | Details |
Nostopeptin B | C46H70N8O12 | 185980-89-6 | Details |
NPD9948;NPD-9948;NPD 9948 | C13H14N6 | 59856-85-8 | Details |
SCH-50910 free base;SCH 50910;SCH50910 | C8H15NO3 | 790633-59-9 | Details |
BZAD01;BZAD-01;BZAD 01 | C16H12F6N2O | 305339-41-7 | Details |
Mebendazole-amine;G1029;R 18986;R-18986;G-1029;G 1029;R18986 | C14H11N3O | 52329-60-9 | Details |
Flecainide;Tambocor;Flecainidum;Flecainida;Apocard | C17H20F6N2O3 | 54143-55-4 | Details |
Droxicam | C16H11N3O5S | 90101-16-9 | Details |
7-Methyladenine | C6H7N5 | 935-69-3 | Details |
Pirlindole free base;Pirlindole;Pyrazidol | C15H18N2 | 60762-57-4 | Details |
SL-01 | C18H18ClNO3 | 26049-94-5 | Details |
Desethylamiodarone;LB33020;N-Deethylamiodarone;LB 33020;N-Monodesethylamiodarone;DAMI;LB-33020 | C23H25I2NO3 | 83409-32-9 | Details |
(-)-Chromanol 293B;(-)-[3R,4S]-Chromanol 293B | C15H20N2O4S | 163163-24-4 | Details |
Phenol, 4-chloro-5-methyl-2-nitro- | C7H6ClNO3 | 7147-89-9 | Details |
1-Phenylpyrrole;NSC 16581;NSC16581;NSC-16581 | C10H9N | 635-90-5 | Details |
2-PADQZ;2PADQZ;2 PADQZ;2-PADQZ | C14H19N5O2 | 60547-97-9 | Details |
Uridine triacetate | C15H18N2O9 | 4105-38-8 | Details |
Olopatadine;Patanol;Opatanol;KW-4943A;KW-4679 | C21H23NO3 | 113806-05-6 | Details |
Cloransulam-methyl | C15H13ClFN5O5S | 147150-35-4 | Details |
5M038 | C17H8F6N4 | 338962-32-6 | Details |
C.I. 37505;3-Hydroxy-2-naphthanilide;2-Naphthanilide, 3-hydroxy- (8CI) | C17H13NO2 | 92-77-3 | Details |
A-7 hydrochloride | C20H29Cl2NO2S | 79127-24-5 | Details |
Y-27632 | C14H21N3O | 146986-50-7 | Details |
Indoleacetyl phenylalanine;Indol-3 acetyl phenylalanine;Indoleacetyl-phenylalanine;Indoleacetylphenylalanine | C19H18N2O3 | 57105-50-7 | Details |
RP 67580 | C29H30N2O2 | 135911-02-3 | Details |
Ro 20-1724;4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone;Ro20-1724;Ro-20-1724 | C15H22N2O3 | 29925-17-5 | Details |
ATP | C10H16N5O13P3 | 56-65-5 | Details |
Ethyl 4-hydroxyphenylacetate | C10H12O3 | 17138-28-2 | Details |
Nitrophenide | C12H8N2O4S2 | 537-91-7 | Details |
Dicapthon;Captex;AC-4124;ENT-17035;AC4124;ENT 17035;AC 4124 | C8H9ClNO5PS | 2463-84-5 | Details |
3-Nitrophenetole;AI3-15391;AI315391;AI3 15391 | C8H9NO3 | 621-52-3 | Details |
C.I. 15670;NSC-12453;NSC 12453;NSC12453 | C16H11N2NaO5S | 2092-55-9 | Details |
TIPP;Tyr-Tic-Phe-Phe-OH | C37H38N4O6 | 146369-65-5 | Details |
Ertapenem;MK0826;Invanz;MK 0826;MK-0826 | C22H25N3O7S | 153832-46-3 | Details |
Product Total: Product Page: | ||||
150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 |